| 000 | 01563 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513031358.0 | ||
| 264 | 0 | _c19950222 | |
| 008 | 199502s 0 0 eng d | ||
| 022 | _a0020-7136 | ||
| 024 | 7 |
_a10.1002/ijc.2910600419 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHorn-Lohrens, O | |
| 245 | 0 | 0 |
_aShedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4). _h[electronic resource] |
| 260 |
_bInternational journal of cancer _cFeb 1995 |
||
| 300 |
_a539-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xbiosynthesis |
| 650 | 0 | 4 |
_aAntibodies, Neoplasm _xbiosynthesis |
| 650 | 0 | 4 | _aAntibody Specificity |
| 650 | 0 | 4 | _aAntigen-Antibody Reactions |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 | _aEpitopes |
| 650 | 0 | 4 |
_aHodgkin Disease _ximmunology |
| 650 | 0 | 4 |
_aKi-1 Antigen _xbiosynthesis |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 |
_aTumor Cells, Cultured _ximmunology |
| 700 | 1 | _aTiemann, M | |
| 700 | 1 | _aLange, H | |
| 700 | 1 | _aKobarg, J | |
| 700 | 1 | _aHafner, M | |
| 700 | 1 | _aHansen, H | |
| 700 | 1 | _aSterry, W | |
| 700 | 1 | _aParwaresch, R M | |
| 700 | 1 | _aLemke, H | |
| 773 | 0 |
_tInternational journal of cancer _gvol. 60 _gno. 4 _gp. 539-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ijc.2910600419 _zAvailable from publisher's website |
| 999 |
_c7529698 _d7529698 |
||